|
HS Code |
769376 |
| Chemical Name | Fonturacetam Hydrazide |
| Cas Number | 77472-71-0 |
| Molecular Formula | C10H13N3O2 |
| Molecular Weight | 207.23 g/mol |
| Appearance | White powder |
| Melting Point | 218-220°C |
| Solubility | Soluble in water |
| Synonyms | Carphedon hydrazide |
| Storage | Store in a cool, dry place |
| Purity | Typically ≥98% |
As an accredited Fonturacetam Hydrazide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Fonturacetam Hydrazide, 10 grams, supplied in a sealed amber glass vial with tamper-evident cap and clear labeling for identification. |
| Shipping | Fonturacetam Hydrazide is shipped in secure, airtight containers compliant with chemical safety regulations. Packaging ensures protection from moisture, light, and physical damage. All shipments include proper labeling, safety data sheets, and documentation. Transport is arranged via accredited carriers, adhering to local and international guidelines for handling and delivery of research chemicals. |
| Storage | Fonturacetam Hydrazide should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of heat or ignition. Keep the container tightly sealed to protect it from moisture and air. Store at a temperature between 2-8°C (refrigerated). Ensure it is clearly labeled and inaccessible to unauthorized personnel, following all applicable safety regulations. |
|
Purity 99%: Fonturacetam Hydrazide with purity 99% is used in nootropic formulation development, where enhanced pharmacological efficacy and batch-to-batch consistency are achieved. Molecular Weight 211.22 g/mol: Fonturacetam Hydrazide with molecular weight 211.22 g/mol is used in medicinal chemistry research, where precise molecular targeting and standardized assay results are ensured. Melting Point 154°C: Fonturacetam Hydrazide with melting point 154°C is used in solid-state synthesis protocols, where thermal stability during processing is maintained. Particle Size <10 µm: Fonturacetam Hydrazide with particle size less than 10 micrometers is used in tablet manufacturing, where uniform dissolution rates and optimal bioavailability are attained. Stability Temperature up to 45°C: Fonturacetam Hydrazide with stability temperature up to 45°C is used in long-term storage solutions, where chemical integrity and performance retention are preserved. Low Moisture Content <0.5%: Fonturacetam Hydrazide with low moisture content below 0.5% is used in encapsulation processes, where improved product shelf life and minimized degradation are realized. Solubility in DMSO 40 mg/mL: Fonturacetam Hydrazide with solubility in DMSO at 40 mg/mL is used in high-throughput screening assays, where reliable compound dispersion and reproducibility are supported. Pharmaceutical Grade: Fonturacetam Hydrazide of pharmaceutical grade is used in clinical trial material preparation, where regulatory compliance and patient safety are prioritized. |
Competitive Fonturacetam Hydrazide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Each batch of Fonturacetam Hydrazide leaves our plant as the result of years spent refining our approach to high-value synthetic intermediates. Originally, Fonturacetam Hydrazide emerged to answer the growing demand for stable, reliable hydrazide forms supporting the work of both laboratories and process plants. Our R&D team threw themselves into the challenge: create a compound with excellent batch-to-batch consistency, good shelf stability, and clear, easy handling—qualities essential for professionals who need predictable results and minimum process interruption.
From day one, our facility has focused on purity, reproducibility, and usability. Each run receives oversight from our process engineers, who monitor parameters and intervene early if a variable drifts from control. We have built sample archiving and reference tracking into our workflow, so it’s simple to compare performance between lots. Technical teams who depend on our product regularly report that Fonturacetam Hydrazide performs as expected, without off-odors or visible particulate. This comes directly from how we control upstream precursors and solvent profiles—details that matter to end-users.
Whether scaling 100 grams for a lab-scale proof or moving to a multikilogram order, the habits and records we maintain become visible to the chemists and engineers using our product. Technical troubleshooting rarely comes down to guesswork, since we can check against historic batch behaviors and make improvements based on live feedback. We recognize that products like Fonturacetam Hydrazide aren’t just bulk chemicals; they’re crucial steps in complex projects involving specialized synthesis or pharmaceutical research.
Users choose Fonturacetam Hydrazide for a reason: it’s not a random hydrazide, but a well-defined molecule with real-world data behind it. Customers checking for a clear white to almost white crystalline powder seldom find off-spec color or forms, because we remain obsessive about our crystallization processes and final drying steps. Moisture, trace solvent levels, and purity checks shape our output, preventing headaches downstream during formulation and analysis.
The product specification expands beyond “minimum purity” claims. It draws on actual analytical benchmarks—melting point profiles, LC-MS and NMR characterization, and impurity mapping—which match up with published reference data. These checks protect chemists from unexpected side reactions in sensitive syntheses. Over the last year, several clients flagged the importance of actual impurity profiles, not just headline purity numbers. By openly reporting what’s there in trace amounts, we earn long-term trust, and process researchers know what options they face if adjustments to protocols become necessary.
In manufacture, it’s common to produce a chemical for its most popular application, then encourage users to “fit” it to other workflows. Fonturacetam Hydrazide breaks away from this pattern. Its main appeal lies in its compatibility with modern high-throughput screening, advanced combinatorial chemistry sets, and as an intermediate for potential active pharmaceutical ingredient (API) research. The molecule balances high reactivity with manageable safety characteristics, which means research teams rarely encounter unexpected hazards or waste.
In experiments requiring a sturdy hydrazide backbone, Fonturacetam Hydrazide finds repeated use as a partner in condensation reactions and hydrazone formation. Those conducting SAR studies or building libraries for CNS-related actives turn to it as a core intermediate. Our notes from customers document its ease of integration into various reaction conditions: mild to moderate heating, common solvents, and compatibility with standard purification techniques. People in our community don’t want to waste hours debugging a single step due to input variability or reactants that don’t dissolve or suspend properly—so our formulation focus stays on flow, granule size, and solubility.
Feedback drives improvements here more than any external consulting can. Early users reported issues with batch caking and handling loss. By listening to operations and supply chain input, we modified our drying schedules and packaging, reducing clumping and improving pourability. This is how we learned firsthand not to treat process additives or particle surface modification as afterthoughts—they matter every day inside real laboratories and kilo-plants.
Fonturacetam Hydrazide isn’t a niche or boutique molecule—its differences from familiar hydrazides lie in what chemists actually experience at the bench. Several generic hydrazides crowd the market, and it’s easy for users to see them as commodities. Engineers who deal with practical problems notice that less-refined products often show erratic particle size, higher moisture pickup, or late-forming by-products under storage. Each one of these issues generates unneeded troubleshooting.
Our direct competitors may offer chemical grade specifications and claim “meets standards.” In our daily practice, we find this doesn’t always line up with what arrives in users’ hands. From its distinctive lot identity system to robust chain-of-custody documentation, every box of Fonturacetam Hydrazide is traceable back to specific reactor runs and testing cycles. If a client reports a field issue or necessary adjustment, our team consults raw instrumentation files to provide immediate, practical support.
Users have told us that switching to Fonturacetam Hydrazide reduced the frequency of unplanned formulation adjustments and cleanroom slowdowns. This comes down to tight control of parameters like residual water, handling dustiness, and contaminant cross-contact, all of which we measure at exit. Over time, a pattern developed: smoother intake in automated dosing systems, cleaner filtrations and crystallizations, and more predictable yields. These are outcomes that matter more than any one technical spec sheet.
Downstream project managers use Fonturacetam Hydrazide in several major areas: CNS drug discovery pipelines, solvent-phase condensation as a key step in scaffold construction, and in some cases for academic projects testing novel bioisostere approaches. Each application brings separate challenges. Some research teams run into issues with competing side products, so they demand a hydrazide source low in color-producing impurities or long-lived hydrophobic traces. Others focus on time savings, where a consistent-dissolving powder shaves hours off of batch prep and qualification.
More recently, process chemists have explored Fonturacetam Hydrazide as a component in parallel library synthesis. In these settings, automation and rapid screening put pressure on suppliers to deliver close, reproducible lots over many months. Pulling data from our supply to these projects, our records show less than 0.2% deviation in key analytical endpoints between lots, giving scientists confidence to simplify their QC steps. Some academic groups told us it allowed them to meet grant milestones they would have missed using inconsistent inputs.
Contract research organizations, running under tight regulatory or client-driven specifications, lean on traceable outcomes and detailed COAs. Our experience as a manufacturer, not a repackager, means we address these needs without delay. We view every project as a partnership: if a customer uncovers a new use case, our support and technical information flow directly from production without the lag of waiting on a third party.
Pressures are changing fast in the synthetic chemical field. Regulatory demands tighten, customers face stricter impurity and traceability rules, and faster scale-up pushes suppliers to cut corners just to keep up. We hold the perspective that investing in more detailed analytics, stable supply agreements, and supporting staff training returns value multifold—short-term shortcuts produce only headaches for both us and the end user.
As new synthetic routes for similar hydrazides continue to emerge, we routinely review published methods and integrate improvements into real production. Our team collaborates with research groups who focus on green chemistry enhancements, and we continually tweak solvent recovery, process intensification, and waste minimization steps based on evidence. Not every idea pans out, but our direct knowledge of what runs successfully at pilot and full scale means we skip costly trial-and-error in the plant.
Our commitment to transparency and knowledge sharing goes beyond meeting regulatory lines on a document. We have shared anonymized case studies with industry peers—demonstrating problem-solving around impurity reduction, and describing how we reduced solvent waste while controlling final assay. This back-and-forth strengthens the larger chemical community, so the knowledge surrounding Fonturacetam Hydrazide moves forward together, not in isolated silos.
A chemical is only as valuable as the hands that use it capably. Recognizing this, we actively support teams who approach our site for technical walk-throughs, training on safe handling, and guidance on best storage practices. Newer staff joining pharmaceutical process teams particularly benefit from seeing the product lifecycle up close—from reaction kettle to final packaging. These hands-on opportunities resolve confusion around issues like retained moisture impact or crystalline form stability. Our approach demystifies the process, reducing material loss due to guesswork or misinterpretation.
We have contributed practical guides to local training initiatives—designed by operators who know both the science and the messiness of real production. These sessions don’t center on abstract “user requirements,” but instead tackle questions about correct scoop handling, minimizing static buildup, batch relabeling, and rapid identification in a crowded storage environment.
Inside our own company, continuous improvement policies drive cross-team learning. Our operators and QC chemists regularly update protocols based on real use feedback, keeping communication lines open with the customer end as well. We treat user feedback from plant engineers, researchers, and lab assistants with as much seriousness as guidance from senior scientists. As a result, the conversation about Fonturacetam Hydrazide stays alive—and useful—beyond any one lot or customer.
The days of “good enough” chemistry are behind us. Today, professionals want chemicals that anticipate regulatory trends, fit tightly into digital batch documentation systems, and allow for innovation without introducing new risks. Fonturacetam Hydrazide reflects this shift: it isn’t assembled with generic precursors from inconsistent supply chains, and it doesn’t ride through unchecked storage conditions before shipment. From plant controls to documentation, our approach centers on forward compatibility with future standards, so those who invest in development can keep results safe from unpredictable inputs.
Looking out at tomorrow’s requirements, quality won’t just mean hitting assay targets. Ingredient traceability, demonstrated environmental controls, and practical support at the bench level will matter more. We keep ahead by evolving our record-keeping systems and supporting customer trace-back requests, which has helped clients gain faster regulatory clearances and reduces the burden on their own compliance audits.
Rather than chasing “fastest to market,” our focus remains fixed on resilience and data-driven improvement. We’ve watched enough projects founder on the rocks of unexpected lot variability or supply gaps to stay alert to the next round of challenges. In a turbulent market, showing steady, honest leadership by example pulls everyone forward together—no shortcuts, no guesswork, just the results that working chemists require.
Decades spent making, refining, and shipping specialized intermediates have given us a perspective that reaches beyond glossy brochures or generic web listings. In practical, everyday use, Fonturacetam Hydrazide stands for clarity, dependability, and honest communication from plant floor to end bench. It doesn’t promise to solve every problem outright, but it eliminates many avoidable hassles and keeps chemists focused on what matters—achieving breakthrough results, not fighting their starting materials.
The ongoing journey to quality means listening as much as producing. Customers around the world shape our next moves with their questions, reports, and ideas. As chemistry evolves, so will the ways we support and improve the substances that drive science ahead. Each order of Fonturacetam Hydrazide builds on everything that came before—learning from every batch, every reaction, and every discussion. That’s how we make a difference, one molecule at a time.